Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Spruce Biosciences Inc SPRB

Healthcare Biotechnology
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly... see more

Current News (NDAQ:SPRB)

Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital

Business Wire 9 days ago

Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors

Business Wire December 15, 2025

Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Business Wire November 10, 2025

Spruce Biosciences Announces $50.0 Million Private Placement Financing

Business Wire October 8, 2025

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)

Business Wire October 6, 2025

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market

Business Wire September 15, 2025

Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Business Wire August 14, 2025

Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB)

Business Wire August 14, 2025

Spruce Biosciences Announces Reverse Stock Split

Business Wire July 24, 2025
View More News ››

Opinion & Analysis (NDAQ:SPRB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SPRB)

SPRB....What else eh! Run it up to do a Financing

I wonder how many peoples a/c blew up??? What a game eh?   Spruce Biosciences Announces $50.0 Million Private...
Iseneschal - October 8, 2025

RE:Sell buddy sell.Wow.

Way to go Mr. Cool...finally got more than your infamous "Buy Buddy Buy" or "Sell Buddy Sell" Sure would be nice to...
Iseneschal - October 6, 2025

RE:SPRB....this is hilarious

Here is what is reality..... PART I — FINANCIAL INFORMATION Item 1. Financial Statements SPRUCE BIOSCIENCES, INC. CONDENSED...
Iseneschal - October 6, 2025

SPRB....this is hilarious

Here's what they tell you.... SUMMARY OF RISKS ASSOCIATED WITH OUR BUSINESS We face risks and uncertainties associated with our...
Iseneschal - October 6, 2025

Using technical analysis for this stock.

This stock was flying from the pre market action this morning and also into the start of the regular market hours this afternoon,but it...
coolfooldumbguy - October 6, 2025

Sell buddy sell.Wow.

Sold out of this stock at $153.79 cents per share and made a massive profit from this one.
coolfooldumbguy - October 6, 2025
View more Bullboard ››

FPX Nickel Corp.

FPX Nickel Corp.

FPX Nickel Corp., a junior nickel mining company, engages in the acquisition, exploration, and development of mineral ...
View More »

Podcasts